WEIGHT CONTROL AND OBESITY REDUCTION THROUGH DIET AND PHYSICAL ACTIVITY INTERVENTION IN BREAST CANCER SURVIVORS
Antonio Agudo Trigueros
Institut Català d'Oncologia - IDIBELL Institut d'Investigació Biomèdica de Bellvitge IDIBELL
Scientific talent responds to society for the results obtained with the donations made to La Marató
One person in four in Catalonia has diabetes or obesity, the two most frequent metabolic diseases and the ones to which La Marató was dedicated in 2015. The goals of that edition were to raise awareness about diseases that are widespread but are nevertheless surrounded by social lack of understanding, and to boost scientific research in order to gain more years and greater quality of life for people who are affected.
Anna Boadas and Toni Cruanyes on TV3, and Ricard Ustrell on Catalunya Radio, hosted 22 hours of live programming in which awareness-raising, spreading information and entertainment joined hands to give a face to the statistics of diabetes and obesity. Witnesses, doctors and artists in the radio and television studios, along with thousands of members of the public, associations and businesses throughout Catalonia, featured in a day-long charity event that ended with a final scoreboard showing 9.469.226 €.
These resources made it possible for 57 research teams to dedicate these last three years to researching the causes, treatments and prevention of diabetes and obesity through the 33 projects that were funded. They were selected from among the 136 presented in response to the call, in a process of evaluation that was co-ordinated by the Catalan Agency for Health Technology Assessment and Research (AQuAS)), in which 65 international experts in diabetes and obesity assessed their quality, methodology, scientific and social health relevance, innovative value and viability.
Now the Foundation is presenting the result of intense research activity that is the fruit of the support, the emotion, the effort and the social confidence that have made a direct and positive impact on the health of the community as a whole.
57 research teams received grants from La Marató 2015 for 33 projects on diabetes and obesity, some single-centre projects and others co-ordinated in different centres.
WEIGHT CONTROL AND OBESITY REDUCTION THROUGH DIET AND PHYSICAL ACTIVITY INTERVENTION IN BREAST CANCER SURVIVORS
Antonio Agudo Trigueros
Institut Català d'Oncologia - IDIBELL Institut d'Investigació Biomèdica de Bellvitge IDIBELL
LIPOTOXICITY AND MICROVASCULAR DISEASE: CONTRIBUTION TO MYOCARDIAL DAMAGE IN CLINICAL AND EXPERIMENTAL MODELS OF DIABETES
Núria Alonso-Pedrol
IIGTiP Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Josep Julve Gil
IRHSP Institut de Recerca Hospital de la Santa Creu i Sant Pau
TARGETING THE GENETIC CAUSES OF DIABETES THROUGH GENE THERAPY: THERAPEUTIC APPROACHES FOR MODY
Fàtima Bosch Tubert
Centre de Biotecnologia Animal i Teràpia Gènica - Universitat Autònoma de Barcelona
Steve Brown
Medical Research Council – Oxfordshire
Martin Hrabe de Angelis
Helmholtz Center Munich, German Research – Neuherberg
CONTROL OF SYSTEMIC AND TISSUE-SPECIFIC OBESITY-INDUCED INSULIN RESISTANCE BY NUCLEAR RECEPTORS
M. del Carmen Caelles Franch
Facultat de Farmàcia - Universitat de Barcelona
Annabel Valledor Fernández
Facultat de Biologia - Universitat de Barcelona
Mercedes Ricote Pachec
CNIC Centro Nacional de Investigaciones Cardiovasculares Carlos III – Madrid
ROLE OF RELEASED AND EXOSOMIAL MICRORNAS, INFLAMMATORY AND DIABETES ASSOCIATED (REX-MIDAS), IN ENDOTHELIAL METABOLIC MEMORY
Antonio Ceriello
IDIBAPS Institut d'Investigació Biomèdica August Pi i Sunyer
COMBINATORIAL GENE THERAPY STRATEGY TO TARGET OXIDATIVE AND ENDOPLASMIC RETICULUM STRESSES IN TYPE 2 DIABETIC NEUROPATHY
Miguel Chillón Rodríguez
Institut de Neurociències - Universitat Autònoma de Barcelona
POLYGENIC RISK SCORES AND TYPE 2 DIABETES: MODULATION BY OBESITY AND DIETARY INTERVENTION IN DETERMINING DIABETES INCIDENCE AND CARDIOVASCULAR DISEASES
Dolores Corella Piquer
Facultat de Medicina - Universitat de València
DIABETES PREVENTION: TRANSLATING A FEASIBLE AND COST-EFFECTIVE LIFESTYLE INTERVENTION INTO PRIMARY CARE TO REDUCE THE SOCIAL BURDEN OF TYPE 2 DIABETES. THE DP-TRANSFERS PROJECT
Bernardo Costa Pinel
IDIAP Institut d'Investigació en Atenció Primària Jordi Gol – Reus
ENCAPSULATED SYNTHETIC CELLULAR CIRCUITS TO RESTORE GLYCEMIC CONTROL IN TYPE 1 DIABETES
Rubén Díaz Naderi
Hospital Sant Joan de Déu – Esplugues de Llobregat
Francesc Posas Garriga
Institut de Recerca Biomèdica de Barcelona
Gorka Orive Arroyo
Facultad de Farmacia - Universidad del Pais Vasco
MODELING THREE-DIMENSIONAL CHROMOSOMAL STRUCTURE IN BETA CELLS TO IDENTIFY GENETIC MECHANISMS UNDERLYING TYPE 2 DIABETES
Jorge Ferrer Marrades
IDIBAPS Institut d'Investigació Biomèdica August Pi i Sunyer
Marc A. Martí-Renom
Centre Nacional d'Anàlisi Genòmica - CRG Centre de Regulació Genòmica
José Luis Gómez Skarmeta
Centro Andaluz de Biología de Desarrollo - CSIC Consejo Superior de Investigaciones Científicas
IDENTIFICATION OF MOLECULAR MEDIATORS OF SIGNALLING FROM INTESTINE TO INSULIN SENSITIZATION AND THE BROWNING OF ADIPOSE TISSUE: ROLE OF LBP AND FGF15/19
Marta Giralt Oms
Facultat de Biologia - Universitat de Barcelona
José María Moreno Navarrete
Hospital Dr. Josep Trueta - IDIBGi Institut d'Investigació Biomèdica de Girona
LIVER GLYCOGEN, A NOVEL TARGET TO TREAT DIABETES AND OBESITY
Joan J. Guinovart Cirera
IRBB Institut Recerca Biomèdica de Barcelona
CHRONONUTRITION AND CHRONOTYPE AND THEIR RELATIONSHIP WITH OBESITY AND TYPE II DIABETES
Paula Jakszyn
Institut Català d'Oncologia - IDIBELL Institut d'Investigació Biomèdica de Bellvitge IDIBELL
PRE-CLINICAL ALZHEIMER'S DISEASE AND TYPE 2 DIABETES AND OBESITY. EFFECTS OF BARIATRIC SURGERY: A MULTIMODAL STUDY
Amanda Jiménez Pineda
Hospital Clínic i Provincial de Barcelona
Rafael Blesa González
IRHSP Institut de Recerca Hospital de la Santa Creu i Sant Pau
THE IMPACT OF ENERGY METABOLISM ON EPIGENETIC MODIFICATIONS RELATED TO THE COMBINATION OF DIABETES AND OBESITY
Jorge Joven Maried
IISPV Institut d'Investigació Sanitària Pere Virgili – Reus
EXECUTIVE FUNCTION TRAINING IN CHILDHOOD OBESITY: FOOD CHOICE, QUALITY OF LIFE AND BRAIN CONNECTIVITY (TOUCH)
María Ángeles Jurado Luque
Institut de Neurociències - Universitat de Barcelona
RESTRICTING OBESITY: ANTI-S6K1 THERAPY
Sara Catherine Kozma
IDIBELL Institut d'Investigació Biomèdical Hospital Univesitari de Bellvitge
SCHOOL-BASED BEHAVIOURAL INTERVENTION TO FACE OBESITY AND PROMOTE CARDIOVASCULAR HEALTH AMONG SPANISH ADOLESCENTS: A CLUSTER-RANDOMIZED CONTROLLED TRIAL
Rosa Maria Lamuela Raventós
Facultat de Farmàcia Universitat de Barcelona - Fundació Bosch i Gimpera
Gloria Santos Beneit
Foundation for Science, Health and Education Fundación She – Barcelona
Juan Miguel Fernández Alvira
CNIC Centro Nacional de Investigaciones Cardiovasculares Carlos III – Madrid
SELECTIVE TARGETING OF INFLAMMATORY FUNCTIONS OF FAT-ACTIVATED MACROPHAGES FOR THE TREATMENT OF OBESITY-ASSOCIATED TYPE-2 DIABETES
Cristina López Rodríguez
Facultat de Ciències de la Salut i Vida – Facultat Pompeu Fabra
Ángel Luis Corbi López
Centro de Investigaciones Biológicas - CSIC Consejo Superior de Investigaciones Científicas
STUDY OF NEW MOLECULAR TARGETS IN PRECLINICAL MODELS OF OBESITY
Elena Martín Garcia
Laboratori de Neurofarmacologia - Universitat Pompeu Fabra
Mara Dierssen Sotos
CRG Centre de Regulació Genòmica
Emmanuel Valjent
Institut de Génomique Fontionnelle INSERM – Montpellier
URBAN ENVIRONMENT AND CHILDHOOD OBESITY IN CATALONIA (ECHOCAT)
Vrijheid Martine
Institut de Salut Global de Barcelona
Talita Duarte Sallés
IDIAP Institut d'Investigació en Atenció Primària Jordi Gol – Reus
DIETARY PATTERNS IN WEIGHT GAIN AND OBESITY INCIDENCE IN CHILDREN AT THE AGES OF 4 AND 7 YEARS IN A BIRTH COHORT IN SPAIN
Eva María Navarrete Muñoz
CIBER Facultad de Medicina – Universidad Miguel Hernández Alacant
RELEVANCE OF THE CLUSTER MIR-424(322)/503 IN THE DEVELOPMENT OF HYPERPLASTIC ADIPOSE TISSUE
Francisco José Ortega Delgado
Hospital Dr. Josep Trueta - IDIBGi Institut d'Investigació Biomèdica de Girona
David Llobet Navas
IDIBELL Institut d'Investigació Biomèdica de Bellvitge
BETA CELLS CIS-REGULATORY NETWORKS AND TYPE 1 DIABETES
Lorenzo Pasquali
HUGTiP Institut d'Investigació Hospital Universitari Germans Trias i Pujol
LIPID DROPLET OVERLOADING PROMOTES PATHOGENESIS AND PROGRESSION OF TYPE 2 DIABETES: IDENTIFYING NEW THERAPEUTIC TARGETS AND APPLYING UPGRADED THERAPIES
Albert Pol Sorolla
IDIBAPS Institut d'Investigació Biomèdica August Pi i Sunyer
POTENTIATION OF MITOCHONDRIAL ACTIVITY IN ADIPOSE TISSUE AS A THERAPEUTIC STRATEGY FOR OBESITY AND TYPE 2 DIABETES: INTERPLAY BETWEEN OXYGEN SENSING AND NEUREGULIN SIGNALLING
Wifred Ricart Engel
Hospital Dr. Josep Trueta - IDIBGi Institut d'Investigació Biomèdica de Girona
Julián Aragonés López
Instituto de Investigación Sanitaria – Hospital Universitario de La Princesa Madrid
Marta Camps Camprubí
Facultat de Biologia - Universitat de Barcelona
CARNITINE PALMITOYLTRANSFERASE 1-MEDIATED STRATEGIES TO ACTIVATE BROWN FAT AND REDUCE FOOD INTAKE TO FIGHT AGAINST OBESITY
Dolors Serra Cucurull
Facultat de Farmàcia - Universitat de Barcelona
Núria Casals Ferré
Facultat Medicina i Ciències de la Salut - Universitat Internacional de Catalunya
TOPICAL ADMINISTRATION OF GLP-1: A NEW STRATEGY FOR TREATMENT OF DIABETIC RETINOPATHY
Rafael Simó Canonge
VHIR Institut de Recerca Hospital Universitari Vall d'Hebron
PREVENTION AND REVERSION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG OBESE PATIENTS BY MEANS OF CUSTOMIZED NUTRITIONAL AND PHYSICAL ACTIVITY INTERVENTION
Josep Antoni Tur Marí
Facultat de Ciències – Universitat de les Illes Balears
ANALYSES OF THE GLOBAL KINASE ACTIVITIES IN ADIPOSE TISSUE TO FIND MOLECULAR DIFFERENCES RESULTING FROM INSULIN RESISTANCE ACROSS DIFFERENT CLINICAL PHENOTYPES FROM LEAN TO OBESE AND TYPE 2 DIABETIC PATIENTS. DISCOVERY OF NEW TARGETS FOR THERAPY
Joan Vendrell Ortega
Hospital Universitari Joan XXIII - Institut d'Investigació Sanitària Pere Virgili Reus
Lluís Fajas Coll
Faculté de Biologie et de médecine - Université de Lausanne
A NEW DAWN FOR TYPE 1 DIABETES: COMBINING A NANOTHERAPY TO HALT AUTOIMMUNITY WITH Β-CELL REGENERATION
Marta Vives Pi
HUGTiP Institut d'Investigació Hospital Universitari Germans Trias i Pujol
EVALUATION OF MICROVASCULAR CHANGES IN THE PERIFOVEAL VASCULAR NETWORK USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY (OCT-A) IN TYPE I DIABETES MELLITUS
Javier Zarranz Ventura
Hospital Clínic i Provincial de Barcelona
MECHANISMS RESPONSIBLE FOR THE DEFECTIVE DIFFERENTIATION CAPACITY OF ADIPOSE-DERIVED STEM CELLS IN OBESITY: IDENTIFICATION OF NEW REGULATORS AMENABLE FOR THE DEVELOPMENT OF INNOVATIVE THERAPIES
Antonio Zorzano Olarte
IRBB Institut Recerca Biomèdica de Barcelona
Sonia Fernández Veledo
Hospital Universitari Joan XXIII - Institut d'Investigació Sanitària Pere Virgili Reus
